Zusammenfassung
Die Depression ist ein unabhängiger Risikofaktor für die Entstehung und einen ungünstigen Verlauf einer kardiovaskulären Erkrankung. Dabei spielen depressionsassoziierte Veränderungen biologischer Parameter sowie Verhaltensvariablen eine wichtige Rolle. Diese Faktoren werden als mögliche Mechanismen in diesem Beitrag näher erläutert. Zu den möglichen biologischen Faktoren gehören Veränderungen des autonomen Nervensystems, der Hypothalamus-Hypophysen-Nebennierenrinden-Achse, des Immunsystems sowie des Gerinnungssystems. Zusätzlich steigt durch eine Depression das Risiko für weitere Erkrankungen, wie Diabetes oder Adipositas, die selbst ein erhöhtes kardiovaskuläres Risiko beinhalten. Auf der Verhaltensebene finden sich oft Veränderungen hin zu einem ungesunden Lebensstil, z. B. durch vermehrtes Rauchen und körperliche Inaktivität. Eine Depression erschwert außerdem erforderliche Verhaltensänderungen und eine Medikamentenadhärenz. Bei der antidepressiven Medikation wiederum muss das kardiovaskuläre Risikoprofil verschiedener Substanzen bedacht werden. Alle diese Faktoren spielen eine wichtige Rolle im Zusammenhang zwischen Depression und kardiovaskulären Erkrankungen.
Summary
Major depression is an independent risk factor for the development of cardiovascular disease. In patients with existing cardiovascular disease, major depression has a large impact on the quality of life and is associated with a poor course and prognosis. Potential mechanisms responsible for this association can be categorized as biological and behavioural variables that do not exclude each other but interact. Biological factors include alterations of the autonomous nervous system, the hypothalamic-pituitary-adrenal axis, the immune system and the vascular system. Major depression also raises the risk for further diseases, such as diabetes mellitus or obesity, which themselves are associated with higher cardiovascular risks. On a behavioural level, depression is often associated with an unhealthy life style such as smoking and physical inactivity. Additionally, depressed patients have more difficulties to implement recommended behavioural changes and to adhere to medication. Furthermore, some classes of antidepressants may also increase cardiovascular risk. All these factors play an important role in the association between depression and cardiovascular disease.
Literatur
Barth J, Schumacher M, Herrmann-Lingen C (2004) Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 66:802–813
Benedict CR, Shelton B, Johnstone DE et al (1996) Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 94:690–697
Black PH (2002) Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 16:622–653
Blumenthal JA (2011) New frontiers in cardiovascular behavioral medicine: comparative effectiveness of exercise and medication in treating depression. Cleve Clin J Med 78(Suppl 1):35–43
Bonnet F, Irving K, Terra JL et al (2005) Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis 178:339–344
Bornstein SR, Schuppenies A, Wong ML et al (2006) Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol Psychiatry 11:892–902
Carnethon MR, Biggs ML, Barzilay JI et al (2007) Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med 167:802–807
Carney RM, Freedland KE, Stein PK et al (2003) Effects of depression on QT interval variability after myocardial infarction. Psychosom Med 65:177–180
Carney RM, Freedland KE, Veith RC et al (1999) Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry 45:458–463
Carney RM, Howells WB, Blumenthal JA et al (2007) Heart rate turbulence, depression, and survival after acute myocardial infarction. Psychosom Med 69:4–9
Deuschle M, Weber B, Colla M et al (1998) Effects of major depression, aging and gender upon calculated diurnal free plasma cortisol concentrations: a re-evaluation study. Stress 2:281–287
Frasure-Smith N, Lesperance F, Talajic M (1993) Depression following myocardial infarction. Impact on 6-month survival. JAMA 270:1819–1825
Gehi A, Haas D, Pipkin S et al (2005) Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med 165:2508–2513
Glassman AH, O’connor CM, Califf RM et al (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288:701–709
Gold PW, Wong ML, Goldstein DS et al (2005) Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A 102:8303–8308
Golden SH, Lazo M, Carnethon M et al (2008) Examining a bidirectional association between depressive symptoms and diabetes. JAMA 299:2751–2759
Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477–501
Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71:171–186
Kemp AH, Quintana DS, Gray MA et al (2010) Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry 67:1067–1074
Kleiger RE, Miller JP, Bigger JT Jr et al (1987) Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59:256–262
Ladwig KH, Marten-Mittag B, Lowel H et al (2005) C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984–1998. Eur Heart J 26:2537–2542
Lesperance F, Frasure-Smith N, Koszycki D et al (2007) Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 297:367–379
Licht CM, De Geus EJ, Van Dyck R et al (2010) Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol Psychiatry 68:861–868
Lippi G, Montagnana M, Favaloro EJ et al (2009) Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost 35:325–336
Luppino FS, De Wit LM, Bouvy PF et al (2010) Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 67:220–229
Mathers C, Loncar D (2006) Projections of global mortality and burden of disease from to 2030. PLoS Med 3:e442
Nicholson A, Kuper H, Hemingway H (2006) Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 27:2763–2774
O’donnell MJ, Xavier D, Liu L et al (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376:112–123
Otte C, Neylan TC, Pipkin SS et al (2005) Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study. Am J Psychiatry 162:2139–2145
Pan A, Sun Q, Okereke OI et al (2011) Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 306:1241–1249
Rugulies R (2002) Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med 23:51–61
Ruo B, Rumsfeld JS, Hlatky MA et al (2003) Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 290:215–221
Serebruany VL, Glassman AH, Malinin AI et al (2003) Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul Fibrinolysis 14:563–567
Taylor CB, Youngblood ME, Catellier D et al (2005) Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 62:792–798
Thombs BD, Bass EB, Ford DE et al (2006) Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 21:30–38
Thorndike AN, Regan S, Mckool K et al (2008) Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Arch Intern Med 168:186–191
Van Melle JP, De Jonge P, Spijkerman TA et al (2004) Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 66:814–822
Van Reedt Dortland AK, Giltay EJ, Van Veen T et al (2010) Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand 122:30–39
Von Kanel R, Bellingrath S, Kudielka BM (2009) Association of vital exhaustion and depressive symptoms with changes in fibrin D-dimer to acute psychosocial stress. J Psychosom Res 67:93–101
Vreeburg SA, Hoogendijk WJ, Van Pelt J et al (2009) Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 66:617–626
Whooley MA (2006) Depression and cardiovascular disease: healing the broken-hearted. JAMA 295:2874–2881
Whooley MA, De Jonge P, Vittinghoff E et al (2008) Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 300:2379–2388
Wulsin LR, Singal BM (2003) Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 65:201–210
Yusuf S, Hawken S, Ounpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952
Interessenkonflikt
Der korrespondierende Autor weist für sich und seine Koautoren auf folgende Beziehungen hin: Christian Otte: Forschungsförderung – Deutsche Forschungsgemeinschaft (Exzellenzcluster NeuroCure, OT 209/7-1), Stiftung Deutsche Depressionshilfe, National Alliance for Research in Schizophrenia and Depression (NARSAD); Beratungstätigkeit – Phineo; Vortragshonorare – Astra Zeneca, Berlin Chemie, Lundbeck, Servier.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kuehl, L., Penninx, B. & Otte, C. Depression: Risikofaktor für kardiovaskuläre Erkrankungen. Nervenarzt 83, 1379–1384 (2012). https://doi.org/10.1007/s00115-012-3584-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-012-3584-8